FindTrial
Sign In

A retrospective study for the preventive effects of warfarin on post-TIPS portal vein thrombosis in cirrhotic patients

A retrospective study for the preventive effects of warfarin on post-TIPS portal vein thrombosis in cirrhotic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021817
Enrollment
Unknown
Registered
2019-03-11
Start date
2019-03-18
Completion date
Unknown
Last updated
2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis

Interventions

1:Warfarin
2:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Cirrhotic patients who received TIPS but did not have portal vein thrombosis before TIPS and the follow-up lasted for 1 year or more.

Exclusion criteria

Exclusion criteria: (1) Previous TIPS placement or liver transplantation; (2) Using anticoagulants or antiplatelet drugs within 3 months prior to TIPS; (3) Platelet count 2; (4) Diagnosied with malignancy; (5) Child-Pugh score > 13; (6) Heart failure; (7) Renal dysfunction; (8) Missing primary outcome during follow-up perio.

Design outcomes

Primary

MeasureTime frame
Incidence of Portal Vein Thrombosis;The location of portal vein thrombosis;—

Countries

China

Contacts

Public ContactHao Wu

West China Hospital, Sichuan University

594264513@qq.com+86 028 85422386

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026